why uganda · - why uganda uganda - an ideal production platform to serve the domestic and regional...
TRANSCRIPT
www.ugandainvest.go.ug 1
WHY UGANDA
Pharmaceuticals production- Why Uganda
Uganda - An idealproduction platformto serve the domesticand regional market
Uganda combines agrowing pharma marketwith access to the EACmarket of 175 millionpeople. With relativelyhigh levels of education and skills and an investor-friendlyenvironment, Ugandais a burgeoningpharmaceutical centre
PHAR
MAC
EUTI
CAL
S
www.ugandainvest.go.ug 2
Uganda - Gateway to one of Africa’s largest pharmaceuticals marketDomestic Market Opportunity
Regional Market Opportunity
www.ugandainvest.go.ug 2 www.ugandainvest.go.ug 3
Availability of a Skilled Workforce Workforce Recruitment, Training and Participation
Early-Mover Advantage
Management & Technical Employees
Management & Technical Employees
Labour force increase(average annual growth, 2018-2022)
Availability of employees (2017)
www.ugandainvest.go.ug 4
Pharma Graduate Courses and Research Institutes
Pharma related colleges and courses in Uganda (2019)
Pharma related research institutions and research centres in Uganda (2019)
Political and Economic Stability and Security
No
No
College Course
Institution or Department
URL
URL
www.ugandainvest.go.ug 4 www.ugandainvest.go.ug 5
Investor-Friendly
Regulatory Environment for the Pharmaceutical Sector
FDI Track Record
Labour Costs
Uganda - Cost Advantages for PharmaceuticalsInvestments
www.ugandainvest.go.ug 6
Average annual labour costs for a highly skilledproduction operative, wages + social security (USD)
Tariffs and Local Sourcing Requirements
Electricity Costs
Special Zones and Incentives
www.ugandainvest.go.ug 6 www.ugandainvest.go.ug 7
Pharmaceutical products proposed for 25% Common External Tariff (CET) inthe EAC
No Formulation
Pharmaceuticals Sector Size in Uganda
Medical Consumables Sector in Uganda
Chemicals (includes Pharmaceuticals) as % of manufacturing value added
Strength of the Pharmaceutical Industry in Uganda
www.ugandainvest.go.ug 8
PHAR
MAC
EUTI
CAL
S
Get in touch
Sector information research carried out in collaboration with DFID, UK